PMID: 6538456May 1, 1984Paper

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

Cancer
J A KishM Al-Sarraf

Abstract

The combination of cisplatin and 96-hour infusion of 5-fluorouracil (5-FU) was evaluated in 30 patients with recurrent (local and regional) and disseminated histologically proven epidermoid cancer of the head and neck who failed surgery and radiotherapy. Cisplatin 100 mg/M2 intravenous (IV) bolus was given on day 1 with hydration and mannitol diuresis; 5-FU 1000 mg/M2 per day for 96-hour infusion was started immediately after cisplatin on day 1. All patients had measurable lesions. Eight (27%) patients achieved complete response (CR), and 13 (43%) had partial response (PR). Overall response rate was 70% (8 of 30 CR and 13 of 30 PR). Response rate in patients with recurrent local and regional disease was 89% (17/19) with median survival of 32 weeks, while response in patients with disseminated disease was 36% (4/11) with median survival of 24 weeks. Patients with good performance status (PS) (greater than or equal to 70%) had a response rate of 79% (19/24), while those with poor PS (less than 70%) had a response rate of 33% (2/6). Seven patients with recurrent disease who had a response to this chemotherapy went to further salvage surgical procedures. It is concluded that the combination of cisplatin and 5-FU is very effective a...Continue Reading

References

Nov 1, 1978·Cancer·C JacobsR L Goode
Apr 1, 1981·Archives of Otolaryngology·T J ErvinM Meshad

❮ Previous
Next ❯

Citations

May 1, 1995·Seminars in Surgical Oncology·W Liggett, A A Forastiere
Jan 1, 1987·Cancer Metastasis Reviews·M Al-Sarraf
Dec 13, 1985·Pharmaceutisch Weekblad. Scientific Edition·D T SleijferN H Mulder
Jun 19, 1992·Pharmaceutisch Weekblad. Scientific Edition·T J HodesJ H Beijnen
May 14, 2005·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Angel Segura HuertaJoaquín Montalar Salcedo
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·S El-SayedJ McGarva
Jan 1, 1999·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·D PassaliG Franci
Feb 24, 2007·Journal of Bioenergetics and Biomembranes·Kevin J CullenZhongmin Guo
Jan 19, 2012·Current Treatment Options in Oncology·Katharine A R Price, Ezra E Cohen
Mar 1, 1986·Psychiatry Research·L A Gottschalk, J Hoigaard-Martin
Sep 1, 1994·European Journal of Cancer. Part B, Oral Oncology·M MerlanoM Rosso
Oct 1, 1996·Critical Reviews in Oncology/hematology·D J AdelsteinP Lavertu
Sep 1, 1987·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J W LeerE van der Schueren
Apr 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F LewinU Ringborg
Dec 1, 2001·International Journal of Radiation Oncology, Biology, Physics·S A SpencerR Meredith
Dec 3, 2002·International Journal of Radiation Oncology, Biology, Physics·Mohammed BerradaShirley Lehnert
Jan 1, 1993·Clinical Oncology : a Journal of the Royal College of Radiologists·E JunorH Yosef
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M. G. EtcheverryA. Nuñez De Pierro
Feb 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C M NuttingK J Harrington
Aug 26, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R HittUNKNOWN Spanish Head and Neck Cancer Cooperative Group (TTCC)
Dec 18, 1998·American Journal of Clinical Oncology·L Sadoff
Dec 7, 2010·Anti-cancer Drugs·Yann Molin, Jérôme Fayette
Aug 7, 2009·Drugs & Aging·Yassine LalamiAhmad Awada
May 4, 2011·Expert Review of Anticancer Therapy·Jean-Pascal Machiels, Sandra Schmitz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.